UK-based microbiome firm Eagle Genomics is to enter into a pact with Cargill as part of a multi-year deal looking to harness artificial intelligence (AI) to the agricultural commodity giant’s microbiome and life sciences R&D.
Worldwide demand for immunity products is likely to deliver a permanent ‘new norm’ of higher growth for these types of supplements and brands will need to innovate to meet heightened demands, according to the boss of global nutraceutical developer SIRIO...
The UK’s most prominent scientists are asking the country’s health secretary Matt Hancock to assess the role of the gut microbiome in coronavirus citing evidence that points to its impact on susceptibility and recovery from the disease.
The UK’s Advertising Standards Authority (ASA) is instructing a probiotics firm and aesthetic clinic to revise claims made on its ads that the watchdog says exploits health related anxieties during the current crisis.
LIVE NUTRAINGREDIENTS WEBINAR SERIES: 26 MAY – 25 JUNE 2020
Highly anticipated news of taxonomic changes to the genus Lactobacillus this month would have been unlikely to cross the average consumer's radar but the update is a great and surprisingly timely communication opportunity, explains Kristina Campbell,...
Supplementation of a probiotic blend of Lactobacilli strains appear to reduce the reoccurrence of Bacterial Vaginosis (BV) in women recently treated with antibiotics, according to a team of scientists.
As demand for dietary supplements continues to surge, immune products, including probiotics, are among the most in-demand. We spoke to some leading probiotic players to find out how supply is being impacted by the novel coronavirus and what the next 3-6...
Holland & Barrett staff have set up a petition, signed by thousands of staff and customers, begging the company to close its stores during the coronavirus pandemic as they argue their lives and the lives of customers are being put at risk.
Industry experts have slammed statements made in a recent JAMA Viewpoint that called for probiotics to be regulated to the same standard as drugs, and decried the “paucity of high-quality data supporting the value of probiotics”.